Virtual Medicinal Product (VMP) - Buprenorphine 300micrograms/1ml solution for injection ampoules

Navigation

Name Details

Name Start Date End Date
Name Current Name Buprenorphine 300micrograms/1ml solution for injection ampoules Start Date 17-05-2004 End Date
Previous Name Previous Name Buprenorphine 300micrograms/ml injection 1ml ampoules Start Date 13-01-2003 End Date 16-05-2004
Abbreviated Name Abbreviated Name Buprenorphine 300micrograms/1ml inj ampoules Start Date 01-05-2009
Previous Abbreviated Name Buprenorphine 300micrograms/1ml soln for inj ampoules Previous Start Date 07-09-2004 Previous End Date 30-04-2009

Unit Dose & Form Information

DF Indicator
Discrete
UDFS Indicator
1
UDFS UOM
ml
Unit Dose UOM
ampoule

Summary

Prescribing Status
Valid as a prescribable product
Controlled Drug Category
Schedule 3 (CD No Register)
Route
Intramuscular, Intravenous
Form
Solution for injection
Ontology Form/Route
solutioninjection.intramuscular, solutioninjection.intravenous
Non-availability Indicator
Actual Products not Available
Name Basis
rINN - Recommended International Non-proprietary

Codes

ATC Code
N02AE01
BNF Start Date End Date
Current BNF 04070200 Start Date 04-04-2022 End Date
Previous BNF 04070200 Start Date 18-02-2005 End Date 03-04-2022
Previous BNF 04100000 Start Date 18-02-2005 End Date 03-04-2022
SNOMED Codes
Code Start Date End Date
35913611000001107 19-10-2018
322499003 11-08-2006 18-10-2018
3627811000001100 13-01-2003 10-08-2006

VMP Ingredients

VMP ingredients table
Name Basis of Strength Description BOSS Strength and UOM (Nmr) Strength and UOM (Dmr)
Buprenorphine hydrochloride Based on Base Substance Buprenorphine 300 microgram 1 ml

Parent Products

Virtual Medicinal Product Pack (VMPP) Information

Pack Size Drug Tariff Price Drug Tariff Payment Category
5 ampoule